Searched for
GSK ONCOLOGY SEGMENT
GSK re-enters India’s cancer drug marketGlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for gyna...25 Aug, 2025, 09.06 PM IST- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...25 Aug, 2025, 01.43 PM IST
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.04 Jul, 2016, 06.01 AM IST
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...23 Dec, 2014, 08.48 PM IST
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.22 Apr, 2014, 06.59 PM IST
- Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...05 Mar, 2013, 04.06 PM IST
- GSK Pharma: New launches, stronger field force could helpNet sales for the quarter have been lower than that logged in the preceding quarters of September and March 2011 and stand almost at the sa...22 Feb, 2012, 03.16 AM IST
- GSK Pharma: Domestic market slump to hurt growth prospectsThe company posted a 13% growth in net sales and 8% growth in operating profit - its best performance in the past three quarters.19 Aug, 2011, 04.41 AM IST
- Glaxosmithkline Pharma: Vaccine business to help maintain margin leadGlaxoSmithKline Pharma has grown across all its business segments and is on track to maintain its target of growing at close to 12-13 % ann...17 Feb, 2011, 06.28 AM IST
- Dr Reddy’s buys GSK’s oral penicillin facility in USDr Reddy’s Laboratories, one of the country’s biggest drug firms, has bought GlaxoSmithKline’s oral penicillin facility and products in the...24 Nov, 2010, 01.34 AM IST
- GSK Pharma: New product pipeline to boost sales growthThe company, which is among the top three players in the domestic market, posted an improved performance across all its business segments o...16 Feb, 2010, 12.59 AM IST
- GSK drug-deal talk lifts DRL scripShares of Dr Reddy’s Laboratories (DRL) touched an intra-day high of Rs 878.70, amid speculation that the Indian drug maker is in prelimina...23 Sep, 2009, 01.19 AM IST
- Dr Reddy's in talks with Glaxo for stake saleMost MNCs are focusing on India and emerging markets to sustain their growth as the US and Europe markets slow down.18 Sep, 2009, 12.04 AM IST
- Dr Reddy's signs pact with GSK; stock up 4%Shares of Dr Reddy’s Laboratories were in the limelight after the pharmaceutical major announced a strategic partnership with GlaxoSmithKli...16 Jun, 2009, 10.50 AM IST
- DRL, GSK ink pact to develop, market genericsDr Reddy’s Laboratories (DRL) has partnered with GlaxoSmithKline (GSK) to develop and market generics and formulations in emerging markets ...16 Jun, 2009, 03.13 AM IST
- Dr Reddy's signs strategic pact with GSKDrug maker Dr Reddy's Laboratories announced a strategic partnership with GlaxoSmithKline Plc to develop and market select products across ...15 Jun, 2009, 07.55 PM IST
- Ranbaxy to enter US anti-cancer segmentIn line with the company’s strategy to focus on speciality drugs in the US, drug major Ranbaxy is set to foray into the anti-cancer drug ma...07 Sep, 2007, 04.03 AM IST
Load More
